** Redcare Pharmacy's RDC.DE shares are up around 3% as
the German online pharma retailer reported a rise in FY sales,
boosted by e-prescriptions
** FY sales grow 32% to EUR 2.4 billion ($2.47 billion)
** Baader Helvea deems the company's preliminary FY sales
figures "strong"
** It points to 142% growth in sales for e-prescriptions in
Germany in Q4, "a clear acceleration" from 7% growth in Q1, 37%
in Q2 and 81% in Q3
** The growth acceleration follows the introduction of
CardLink in early May, a solution by which users can redeem
e-prescriptions via their smartphones, the broker notes
** "Redcare Pharmacy's sales momentum is outperforming the
overall dull online retail sales trends and is, consequently,
gaining market share," it says
($1 = 0.9721 euros)
(Reporting by Linda Pasquini)
((linda.pasquini@thomsonreuters.com))